Scientists funded by Cancer Research UK are using virtual experiments in a bid to find the best methods for drug discovery. The findings have been published in the Nature Reviews Drug Discovery journal, with the work combining a unique ...
Tags: Cancer Research UK, virtual experiments, drug discovery, online database
OPKO Health has signed a definite agreement to acquire Sao Paulo, Brazil based pharmaceutical company Silcon Comércio, Importacao E Exportacao de Produtos Farmaceuticos e Cosmeticos. The acquisition is expected to expand OPKO's ...
Tags: OPKO, pharmaceutical company, test cassettes, commercial synergies
Dendreon Corporation has sold its immunotherapy manufacturing facility (IMF) in Morris Plains, New Jersey, US, to Novartis Pharmaceuticals for $43m. In early 2012, Dendreon had decided to bring down Provenge production at the facility as ...
Tags: Novartis, Dendreon immunotherapy, manufacturing facility, Medicine
The risk of a man developing cancer over his lifetime will increase to one in two by 2027,a new study has suggested. Figures from Cancer Research UK suggest that,within 15 years,50 men out of every 100 are likely to be diagnosed with ...
Tags: cancer, Cancer Research UK, risk
Multi-national biopharmaceutical and diagnostics company OPKO Health has acquired Prost-Data,a Nashville-based CLIA laboratory. Prost-Data,which is doing business as OURLab,has 18 phlebotomy sites throughout the US and an experienced ...
Tags: OPKO, Prost-Data, commercial platform, acquisition
A local couple has helped give a boost to a company's Movember campaign in a big way. Heather Turner, owner of Toppers Pizza Barrie along with her husband Brett, have donated all of the pizzas for the "Armour Lip Charmours" Movember pizza ...
Tags: Heather Turner, Toppers Pizza Barrie, pizza, IT
Each month Vegas Partner Lounge and its 9 casino brands offer unique promotions that centre on specific themes and offer rewards such as Free Spins, Match Bonuses, Cash Giveaways, Loyalty Points and more. November is no different as it ...
Tags: casino brand, promotion, men's health, special cause
ApoCell will present the study abstracts of its circulating tumor cells (CTC) recovery technology at the Molecular Targets and Cancer Therapeutics Conference, which will be held in Dublin, Ireland from 6-9 November 2012. Using a ...
Tags: CTC Recovery Technology, medical study, medical technology
Medical diagnostic services provider CML HealthCare has entered into a license agreement to provide Mitomics' Prostate Core Mitomic test (PCMT) to urologists across Canada. Using the science of mitochondrial DNA analysis, the test ...
An Innisfil woman has joined the local"Armour Lip Charmours"Movember team in an effort to increase awareness and raise funds for prostate cancer research. BARRIE,ON,November 21,2012/24-7PressRelease/--An Innisfil woman has joined ...
Tags: Armour Lip Charmours, Innisfil Woman, Men's Health Issues
Medivation and Astellas Pharma have announced FDA approval for Xtandi (enzalutamide) capsules to treat metastatic castration-resistant prostate cancer in patients with previously received docetaxel. Medivation and Astellas expect to make ...
Tags: Medivation, Astellas, FDA
Janssen's Zytiga indicated for metastatic castration-resistant prostate cancer(mCRPC),has won FDA approval for use in patients who have not received chemotherapy. The oral,once-daily medication was previously used in combination with ...
Tokai Pharmaceuticals has gained FDA fast track designation for galeterone (TOK-001) for the potential treatment of metastatic castration-resistant prostate cancer (CRPC). Galeterone disrupts androgen receptor (AR) signaling, the key ...
Tags: galeterone, TOK-001, castration-resistant prostate cancer, CRPC
Coronado Biosciences has received notice of allowance for US patent application covering CNDO-109, from the US Patent and Trademark Office (USPTO). The patent is entitled, Method for activating natural killer cells by tumor cell ...
Tags: CNDO-109, cancer cells, AML
Chronix Biomedical has opened a fully operational sequencing laboratory in Brookings, South Dakota, US, to expand its commercial capabilities. Chronix has opened the laboratory in association with the First Bank & Trust of Brookings, ...